Nasrien E. Ibrahim

6.4k total citations · 4 hit papers
92 papers, 3.1k citations indexed

About

Nasrien E. Ibrahim is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and General Health Professions. According to data from OpenAlex, Nasrien E. Ibrahim has authored 92 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Cardiology and Cardiovascular Medicine, 21 papers in Surgery and 10 papers in General Health Professions. Recurrent topics in Nasrien E. Ibrahim's work include Heart Failure Treatment and Management (44 papers), Cardiovascular Function and Risk Factors (22 papers) and Cardiac pacing and defibrillation studies (20 papers). Nasrien E. Ibrahim is often cited by papers focused on Heart Failure Treatment and Management (44 papers), Cardiovascular Function and Risk Factors (22 papers) and Cardiac pacing and defibrillation studies (20 papers). Nasrien E. Ibrahim collaborates with scholars based in United States, Netherlands and Canada. Nasrien E. Ibrahim's co-authors include James L. Januzzi, Sean Murphy, Hanna K. Gaggin, Javed Butler, Shweta R. Motiwala, Gregg C. Fonarow, Clyde W. Yancy, Frederick A. Masoudi, Larry A. Allen and Leslie L. Davis and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Nasrien E. Ibrahim

87 papers receiving 3.0k citations

Hit Papers

2021 Update to the 2017 ACC Expert Consensus Decision Pat... 2020 2026 2022 2024 2021 2020 2022 2024 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nasrien E. Ibrahim United States 25 2.2k 540 498 405 274 92 3.1k
Rajat Deo United States 38 3.1k 1.4× 493 0.9× 248 0.5× 432 1.1× 320 1.2× 123 4.6k
Johann Auer Austria 23 2.1k 1.0× 697 1.3× 410 0.8× 485 1.2× 218 0.8× 114 3.2k
Marlies Antlanger Austria 20 1.4k 0.6× 676 1.3× 451 0.9× 479 1.2× 262 1.0× 47 3.1k
Stefano Carugo Italy 32 2.3k 1.0× 681 1.3× 324 0.7× 345 0.9× 267 1.0× 208 3.7k
Katrina Poppe New Zealand 25 2.2k 1.0× 387 0.7× 340 0.7× 307 0.8× 106 0.4× 97 3.0k
Arman Qamar United States 31 2.2k 1.0× 907 1.7× 353 0.7× 395 1.0× 202 0.7× 132 3.4k
Patricia P. Chang United States 27 2.6k 1.2× 394 0.7× 499 1.0× 416 1.0× 546 2.0× 103 4.0k
Morten Schou Denmark 30 1.4k 0.6× 331 0.6× 436 0.9× 296 0.7× 384 1.4× 169 3.0k
Xavier Rosselló Spain 30 1.7k 0.8× 582 1.1× 310 0.6× 182 0.4× 315 1.1× 134 2.9k

Countries citing papers authored by Nasrien E. Ibrahim

Since Specialization
Citations

This map shows the geographic impact of Nasrien E. Ibrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasrien E. Ibrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasrien E. Ibrahim more than expected).

Fields of papers citing papers by Nasrien E. Ibrahim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasrien E. Ibrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasrien E. Ibrahim. The network helps show where Nasrien E. Ibrahim may publish in the future.

Co-authorship network of co-authors of Nasrien E. Ibrahim

This figure shows the co-authorship network connecting the top 25 collaborators of Nasrien E. Ibrahim. A scholar is included among the top collaborators of Nasrien E. Ibrahim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasrien E. Ibrahim. Nasrien E. Ibrahim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Atwater, Susan K., et al.. (2025). Health care access and risk factor control in US adults with cardiovascular disease from 2015 to 2023. American Heart Journal. 290. 238–248.
2.
Blumer, Vanessa, James L. Januzzi, Yuxi Liu, et al.. (2025). Sex Differences in Diabetic Cardiomyopathy and Treatment Response to AT-001. JACC Heart Failure. 14(1). 102433–102433. 1 indexed citations
3.
Marwick, Thomas H., Yuxi Liu, Stefano Del Prato, et al.. (2025). Echocardiographic phenotypes of diabetic myocardial disorder: evolution over 15 months follow-up in the ARISE-HF trial. Cardiovascular Diabetology. 24(1). 16–16. 2 indexed citations
4.
Satti, Danish Iltaf, Eun‐Jung Choi, Harsh Patel, et al.. (2024). Cardiomyopathies in Pregnancy: Trends and Clinical Outcomes in Delivery Hospitalizations in the United States (2005-2020). Current Problems in Cardiology. 49(12). 102855–102855. 2 indexed citations
5.
Januzzi, James L., Stefano Del Prato, Julio Rosenstock, et al.. (2024). Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial. Cardiovascular Diabetology. 23(1). 49–49. 12 indexed citations
6.
López, José, Yuxi Liu, Javed Butler, et al.. (2024). Racial Differences in Diabetic Cardiomyopathy. Journal of the American College of Cardiology. 84(3). 233–243. 4 indexed citations
7.
Januzzi, James L., Javed Butler, Stefano Del Prato, et al.. (2024). Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy. Journal of the American College of Cardiology. 84(2). 137–148. 14 indexed citations
8.
Yehya, Amin, José López, Andrew J. Sauer, et al.. (2024). Revisiting ICD Therapy for Primary Prevention in Patients With Heart Failure and Reduced Ejection Fraction. JACC Heart Failure. 13(1). 1–13. 5 indexed citations
9.
Gouda, Pishoy, Yuxi Liu, Stefano Del Prato, et al.. (2024). Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathy. Cardiovascular Diabetology. 23(1). 281–281.
10.
DeFilippis, Ersilia M., Jaya Batra, Vanessa Blumer, et al.. (2023). Organ Donation and Transplantation among Non-US Citizens: Opportunities to Improve Global Equity in Heart Transplantation. Journal of Cardiac Failure. 29(10). 1383–1393. 1 indexed citations
11.
Maddox, Thomas M., James L. Januzzi, Larry A. Allen, et al.. (2021). 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction. Journal of the American College of Cardiology. 77(6). 772–810. 575 indexed citations breakdown →
12.
McCarthy, Cian P., Franz‐Josef Neumann, Nasrien E. Ibrahim, et al.. (2020). Derivation and External Validation of a High‐Sensitivity Cardiac Troponin–Based Proteomic Model to Predict the Presence of Obstructive Coronary Artery Disease. Journal of the American Heart Association. 9(16). e017221–e017221. 13 indexed citations
13.
Murphy, Sean, Margaret F. Prescott, Alexander Camacho, et al.. (2020). Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction. JACC Heart Failure. 9(2). 127–136. 54 indexed citations
14.
Ibrahim, Nasrien E., Cian P. McCarthy, Shreya Shrestha, et al.. (2019). Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays. Journal of the American College of Cardiology. 73(11). 1273–1284. 95 indexed citations
15.
Natarajan, Pradeep, Zhicheng Jin, Asya Lyass, et al.. (2019). Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death. Journal of the American College of Cardiology. 73(17). 2135–2145. 28 indexed citations
17.
Yancy, Clyde W., James L. Januzzi, Larry A. Allen, et al.. (2017). 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction. Journal of the American College of Cardiology. 71(2). 201–230. 195 indexed citations
18.
McCarthy, Cian P., Roland R.J. van Kimmenade, Hanna K. Gaggin, et al.. (2017). Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study). The American Journal of Cardiology. 120(1). 25–32. 23 indexed citations
19.
Ibrahim, Nasrien E., Hanna K. Gaggin, Dustin J. Rabideau, & James L. Januzzi. (2016). WORSENING RENAL FUNCTION DURING AGGRESSIVE HEART FAILURE MANAGEMENT IS NOT ASSOCIATED WITH POOR OUTCOMES: RESULTS FROM THE PRO-BNP OUTPATIENT TAILORED CHRONIC HEART FAILURE THERAPY (PROTECT) STUDY. Journal of the American College of Cardiology. 67(13). 1339–1339. 3 indexed citations
20.
Mallick, Aditi, Parul U. Gandhi, Hanna K. Gaggin, Nasrien E. Ibrahim, & James L. Januzzi. (2016). The Importance of Worsening Heart Failure in Ambulatory Patients. JACC Heart Failure. 4(9). 749–755. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026